🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the manufacturers of Tylenol, alleging the corporations withheld alleged dangers that the pain reliever presented to children's cognitive development.

This legal action arrives four weeks after President Donald Trump advocated an unverified association between taking acetaminophen - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in young ones.

Paxton is taking legal action against J&J, which once produced the medication, the sole analgesic approved for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a official comment, he claimed they "betrayed America by gaining financially from suffering and promoting medication without regard for the dangers."

The manufacturer states there is no credible evidence connecting acetaminophen to autism.

"These manufacturers deceived for years, knowingly endangering millions to line their pockets," the attorney general, a Republican, said.

The company commented that it was "deeply concerned by the spread of false claims on the security of paracetamol and the potential impact that could have on the well-being of women and children in America."

On its online platform, Kenvue also mentioned it had "regularly reviewed the applicable studies and there is no credible data that shows a established connection between using paracetamol and autism."

Organizations speaking for medical professionals and healthcare providers agree.

The leading OB-GYN organization has stated acetaminophen - the key substance in Tylenol - is one of the few options for pregnant women to address discomfort and fever, which can create significant medical dangers if ignored.

"In more than two decades of studies on the use of acetaminophen in pregnancy, no reliable research has conclusively proven that the consumption of paracetamol in any stage of gestation results in neurological conditions in offspring," the organization stated.

The lawsuit mentions latest statements from the former administration in claiming the drug is reportedly hazardous.

Last month, the former president caused concern from medical authorities when he advised expectant mothers to "resist strongly" not to use Tylenol when unwell.

Federal regulators then published an announcement that doctors should consider limiting the use of acetaminophen, while also mentioning that "a direct connection" between the medication and autism spectrum disorder in minors has not been established.

Health Secretary RFK Jr, who manages the FDA, had pledged in spring to conduct "a massive testing and research effort" that would establish the cause of autism in a short period.

But experts advised that discovering a unique factor of autism spectrum disorder - considered by experts to be the consequence of a intricate combination of genetic and external influences - would be difficult.

Autism is a form of permanent neurological difference and disability that influences how people perceive and engage with the world, and is recognized using physician assessments.

In his lawsuit, the attorney general - aligned with the former president who is running for the Senate - alleges Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the research" around acetaminophen and autism.

The case seeks to make the companies "eliminate any commercial messaging" that states Tylenol is secure for expectant mothers.

The Texas lawsuit echoes the concerns of a collection of parents of young ones with autism spectrum disorder and ADHD who sued the producers of Tylenol in recently.

The court threw out the legal action, saying investigations from the family's specialists was inconclusive.